Form 8-K - Current report:
SEC Accession No. 0001193125-25-149704
Filing Date
2025-06-27
Accepted
2025-06-27 07:00:17
Documents
13
Period of Report
2025-06-26
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d45471d8k.htm   iXBRL 8-K 57677
  Complete submission text file 0001193125-25-149704.txt   211787

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sln-20250626.xsd EX-101.SCH 3535
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sln-20250626_def.xml EX-101.DEF 14078
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sln-20250626_lab.xml EX-101.LAB 22975
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sln-20250626_pre.xml EX-101.PRE 14925
15 EXTRACTED XBRL INSTANCE DOCUMENT d45471d8k_htm.xml XML 6100
Mailing Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH
Business Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH 44-0-20-3457 6900
Silence Therapeutics plc (Filer) CIK: 0001479615 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: 8-K | Act: 34 | File No.: 001-39487 | Film No.: 251082154
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)